Edition:
United States

MyoKardia Inc (MYOK.OQ)

MYOK.OQ on NASDAQ Stock Exchange Global Select Market

35.70USD
22 Nov 2017
Change (% chg)

$-1.15 (-3.12%)
Prev Close
$36.85
Open
$36.95
Day's High
$37.05
Day's Low
$35.65
Volume
104,261
Avg. Vol
152,430
52-wk High
$49.55
52-wk Low
$10.65

Latest Key Developments (Source: Significant Developments)

MyoKardia Inc reports Q3 loss per share $0.42
Thursday, 2 Nov 2017 04:02pm EDT 

Nov 2 (Reuters) - MyoKardia Inc :MyoKardia Inc reports third quarter 2017 financial results and operational progress.Q3 loss per share $0.42.Q3 earnings per share view $-0.41 -- Thomson Reuters I/B/E/S.MyoKardia Inc - ‍collaboration and license revenue was $5.6 million during three months ended September 30, 2017, compared with $3.6 million​.MyoKardia Inc - ‍expects cash, cash equivalents, among others, to enable funding anticipated operating expenses and capex requirements at least into 2020​.  Full Article

MyoKardia expects to initiate next trial of MYK-491 in DCM patients by year-end
Wednesday, 27 Sep 2017 07:30am EDT 

Sept 27 (Reuters) - MyoKardia Inc :MyoKardia provides update on MYK-491 clinical progress.MyoKardia Inc - ‍next trial of MYK-491 in DCM patients expected to initiate by year-end​.MyoKardia Inc says ‍MyoKardia intends to initiate a single ascending dose trial of MYK-491 in symptomatic DCM patients before year-end​.MyoKardia Inc - ‍topline data of Myk-491 expected by early 2018​.  Full Article

MyoKardia announces pricing of public offering of common stock
Tuesday, 8 Aug 2017 09:13pm EDT 

Aug 9 (Reuters) - MyoKardia Inc -:MyoKardia announces pricing of public offering of common stock.Says public offering of 3.50 million common shares priced at $35.50per share.  Full Article

MyoKardia announces proposed public offering of common stock
Monday, 7 Aug 2017 04:01pm EDT 

Aug 7 (Reuters) - Myokardia Inc :Commenced a proposed underwritten public offering of 3.5 million shares of its common stock.  Full Article

Myokardia reports Q2 loss per share $0.41
Monday, 7 Aug 2017 07:19am EDT 

Aug 7 (Reuters) - Myokardia Inc :Myokardia reports second quarter 2017 financial results and operational progress.Qtrly loss per share $0.41.Q2 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S.Myokardia - sees cash, cash equivalents, investments as of June 30 enabling funding of anticipated operating expenses, capex requirements at least into 2019.  Full Article

Myokardia reports positive topline results in Phase 2 pioneer-hcm study of Mavacamten
Monday, 7 Aug 2017 07:00am EDT 

Aug 7 (Reuters) - Myokardia Inc :Myokardia reports positive topline results in Phase 2 pioneer-hcm study of mavacamten (formerly myk-461) in symptomatic, obstructive hypertrophic cardiomyopathy.Myokardia - cohort met primary endpoint of change in post-exercise peak left ventricular outflow tract ) gradient from baseline to week 12.Myokardia inc says that second, low-dose patient cohort in pioneer-hcm has completed enrollment.  Full Article

Myokardia files for offering of up to 9.2 shares of common stock by selling stockholders
Monday, 10 Jul 2017 05:08pm EDT 

July 10 (Reuters) - Myokardia Inc ::Myokardia Inc files for offering of up to 9.2 shares of common stock by the selling stockholders - sec filing.Myokardia Inc says co not selling any shares of common stock and will not receive proceeds from sale of common stock by selling stockholders.  Full Article

Myokardia qtrly net loss per share $ 0.37
Tuesday, 9 May 2017 04:10pm EDT 

May 9 (Reuters) - Myokardia Inc :Myokardia Inc- Collaboration,license revenue $5.6 million during 3 months ended March 31, 2017, versus $3.6 million during three months ended March 31, 2016.Myokardia Inc - qtrly net loss per share attributable to common stockholders $ 0.37.Q2 earnings per share view $-0.33, revenue view $6.3 million -- Thomson Reuters I/B/E/S.  Full Article

Myokardia Q4 net income $14.3 mln
Monday, 13 Mar 2017 08:30am EDT 

Myokardia Inc : Myokardia reports fourth quarter and full year 2016 financial results and operational progress . Myokardia Inc qtrly collaboration and license revenue $28.6 million versus $3.6 million . Myokardia Inc - net income was $14.3 million for Q4 of 2016, compared to a net loss of $7.9 million for Q4 of 2015 .Myokardia- expects existing cash, among others, will enable co to fund operating expenses, capital expenditure requirements at least into 2019.  Full Article

Myokardia says Sanofi has notified company that it has elected to continue global cardiomyopathy research collaboration
Tuesday, 3 Jan 2017 08:30am EST 

Myokardia Inc : Myokardia Inc - Sanofi has notified company that it has elected to continue global cardiomyopathy research collaboration formed in August 2014 . Myokardia Inc - Myokardia is now eligible for a $45 million milestone payment payable by January 31, 2017. .Myokardia Inc - intends to initiate a phase 1 study of MYK-491 in healthy volunteers in first half of 2017..  Full Article

BRIEF-MyoKardia Inc reports Q3 loss per share $0.42

* MyoKardia Inc reports third quarter 2017 financial results and operational progress